European Archives - Page 650 of 1507 - European Medical Journal

Five-Year Outcomes of CD19/CD22 CAR-T Therapy in Post-Allo B-ALL Relapse

The authors have previously reported their Phase I clinical trial regarding a combination treatment of CD19- and CD22-specific chimeric…

Atypical Presentation of Gouty Arthritis: Case Report

Gouty arthritis, also called monosodium urate (MSU) crystal deposition disease, is an inflammatory disease where monosodium urate crystals…

The Impact of ‘Pre-conception’ on Conception: An Inadvertent Form of Infertility

Infertility post stem cell allograft is a common event, with the frequency uncertain because the wish for pregnancy is not commonly…

Agar art

Agar Art and Biosensor Breakthroughs

Maria Eugenia Inda, Pew Postdoctoral Fellow, discusses the development of biosensors for the diagnosis and treatment of inflammatory conditions.

Routine Whole-Genome Sequencing Improves Childhood Cancer Treatment

Clinical whole-genome sequencing of children with cancer demonstrated significant benefits, leading to improved patient management and treatment decisions.

Endometriosis Linked to Heightened Ovarian Cancer Risk

Endometriosis has been associated with an elevated risk of ovarian cancer. However, the associations between endometriosis subtypes and ovarian cancer histotypes remain unknown.

Interview: David Wheeler

When I was a junior doctor, I was exposed to a number of different chronic diseases. However, kidney disease fascinated me the most…

Coin stacks

Agilent Technologies acquires Biovectra for $925m

Agilent Technologies has announced the acquisition of contract drug manufacturing company Biovectra to expand its offerings to biotech companies and medical researchers.

Kyowa Kirin's Danie du Plessis on the potential of patient partnerships

Danie du Plessis, Executive Vice President, Pharmaceutical Operations, Kyowa Kirin, talks about patient partnerships will need to evolve with a changing world, the future of medical affairs and more.

Pregnancy Safety Concerns after Hormone Receptor-Positive Breast Cancer

A new systematic review aimed to provide updated evidence on the safety of pregnancy following hormone receptor-positive early breast cancer.